Evaluation of three novel antigens and costimulatory agents for improvement of M. Tuberculosis specific interferon gamma release assays

Evaluation of three novel antigens and costimulatory agents for improvement of M. Tuberculosis specific interferon gamma release assays

Abstract Background Mycobacterium tuberculosis (MT) infections represent a global health problem and latent tuberculosis infection (LTBI) affects an estimated 25% of the world population. 10.6 million people fell ill with tuberculosis (TB) worldwide in 2021 and a total of 1.6 million TB-associated d...

Full description

Saved in:

Bibliographic Details
Main Authors:	Sandra Schwarzlose-Schwarck, Mark Reinwald, Torsten Bauer, Florian Hentschel, Til Kiderlen, Dorinja Zapf, Victor Herbst, Stefan Lüth, David Krieger, Werner Dammermann
Format:	Article
Language:	English
Published:	BMC 2025-02-01
Series:	BMC Infectious Diseases
Subjects:	Tuberculosis IGRA Complement factors TLR agonists Interferon gamma release assay
Online Access:	https://doi.org/10.1186/s12879-025-10577-3
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Comparative performance of tuberculin and defined-antigen cocktails for detecting bovine tuberculosis in BCG-vaccinated cattle in natural settings
by: Abebe Fromsa, et al.
Published: (2025-02-01)

Mediator kinase inhibition suppresses hyperactive interferon signaling in Down syndrome
by: Kira A Cozzolino, et al.
Published: (2025-02-01)

Pegilated interferon α2а in treatment of chronic hepatitis C
by: P. O. Bogomolov, et al.
Published: (2012-09-01)

Is Combined Bulevirtide and Pegylated Interferon Therapy for Chronic Hepatitis D Superior over Bulevirtide Monotherapy?
by: V. E. Syutkin, et al.
Published: (2020-09-01)

Interferon-free therapy of chronic hepatitis C: replacement of medications or new treatment paradigm?
by: S. N. Batskikh
Published: (2014-10-01)

Platelet-derived HMGB1 induces NETosis, exacerbating brain damage in the photothrombotic stroke model
by: Sang-A. Oh, et al.
Published: (2025-02-01)

The combined therapy of chronic hepatitis with pegilated interferon <i>a</i>-2а and ribavirin in patients with HIV-infection and patients with HCV monoinfection
by: N. D. Yuschuk, et al.
Published: (2009-02-01)

Ultrasensitive interferons quantification reveals different cytokine profile secretion in inflammatory myopathies and can serve as biomarkers of activity in dermatomyositis
by: Loïs Bolko, et al.
Published: (2025-02-01)

Physiological accumulation of lipid droplets in the newborn liver during breastfeeding is driven by TLR4 ligands
by: Wanderson Ferreira da Silva Júnior, et al.
Published: (2025-02-01)

Developing Costimulatory Molecules for Immunotherapy of Diseases /
by: Mir, Manzoor Ahmad
Published: (2015)

Direct immunofluorescence (DIF) versus immunohistochemical (IHC) staining of complements and immunoglobulins (Ig) in pemphigus group
by: Deepika Rana, et al.
Published: (2024-04-01)

TNBC response to paclitaxel phenocopies interferon response which reveals cell cycle-associated resistance mechanisms
by: Nicholas L. Calistri, et al.
Published: (2025-02-01)

The impact of genetic polymorphisms of IL28B gene on the efficacy of antiviral therapy of the chronic hepatitis C by using the standard Interferon-<i>α</i>
by: A. V. Lapshin, et al.
Published: (2013-03-01)

Sarcoid-like reaction at the patient with chronic hepatitis C on a background of antiviral therapy
by: A. V. Lapshin, et al.
Published: (2010-06-01)

On a Certain Lithuanian Purpose Clause Construction
by: Axel Holvoet
Published: (2024-04-01)

Bradykinin B1 receptor signaling triggers complement activation on endothelial cells
by: Ingrid Lopatko Fagerström, et al.
Published: (2025-02-01)

Antiviral therapy and regression of liver fibrosis at chronic hepatitis B
by: D. T. Abdurakhmanov
Published: (2010-02-01)

Preliminary results of open comparative randomized study PHG-M3/P01-09 «ORION» on application of «Phosphogliv» in combined therapy of chronic hepatitis C
by: M. V. Mayevskaya
Published: (2011-06-01)

Results of the ORION open comparative randomized trial: evaluation of efficacy of the Russian drugs Altevir and Phosphogliv in combined treatment of chronic hepatitis C
by: V. T. Ivashkin, et al.
Published: (2012-11-01)

Role of ginsenoside Rg1 as a PPAR-γ activator in protecting against manganese-induced hepatotoxicity: Insights into the TLR4/MyD88/MAPK signaling pathway
by: Mengjing Zhao, et al.
Published: (2025-01-01)

A Systemic Approach to Inceptive Constructions in Lithuanian
by: Rolandas Mikulskas
Published: (2023-12-01)

Inhibition of complement system-related gene ITGB2 attenuates epithelial–mesenchymal transition and inflammation in diabetic nephropathy
by: Jun Peng, et al.
Published: (2025-02-01)

Effective gene therapy for metachromatic leukodystrophy achieved with minimal lentiviral genomic integrations
by: Lucas Tricoli, et al.
Published: (2025-03-01)

Safety and efficacy of telaprevir in treatment of a chronic hepatitis C in patients of the Russian population included in early access program study
by: D. T. Abrurakhmanov, et al.
Published: (2014-07-01)

Interleukin 28B polymorphism impact on early HCV kinetics in HCV-infected liver transplant recipients undergoing antiviral therapy
by: V. E. Syutkin, et al.
Published: (2011-12-01)

A corpus-based analysis of light verb constructions with MAKE and DO in British English
by: Judita Giparaitė
Published: (2024-01-01)

Modeling pegcetacoplan treatment effect for atrophic age-related macular degeneration with AI-based progression prediction
by: Irmela Mantel, et al.
Published: (2025-02-01)

Malaria exposure remodels the plasma proteome of Ghanaian children
by: Aisha M. Mohammed, et al.
Published: (2025-02-01)

Differentially expressed transcript isoforms associate with resistance to tuberculin skin test and interferon gamma release assay conversion.
by: Jason D Simmons, et al.
Published: (2023-01-01)

Forsythia suspensa leaf fermented tea extracts attenuated oxidative stress in mice via the Ref-1/HIF-1α signal pathway and modulation of gut microbiota
by: Lijuan Li, et al.
Published: (2025-02-01)

Inhibition of STING-mediated type I IFN signaling by African swine fever virus DP71L
by: Lakmal Ranathunga, et al.
Published: (2025-02-01)

Prenatal Diagnosis of Maternal-Fetal Blood Subgroup Antigen Incompatibility Due to C Antigen: A Case Report
by: Ebru Biberoğlu, et al.
Published: (2013-08-01)

A GenEO Domain Decomposition method for Saddle Point problems
by: Nataf, Frédéric, et al.
Published: (2023-03-01)

Efficacy and safety of new protease inhibitor faldaprevir in treatment of hepatitis C
by: M. V. Mayevskaya, et al.
Published: (2013-12-01)

Efficacy of pegylated interferon alfa-2b «Algeron» in the treatment of chronic hepatitis C
by: M. V. Mayevskaya, et al.
Published: (2013-03-01)

Mapping naturally presented T cell antigens in medulloblastoma based on integrative multi-omics
by: Julia Velz, et al.
Published: (2025-02-01)

Russian interferon <i>α</i>-2b drug in the treatment of chronic hepatitis C
by: N. B. Kovaleva
Published: (2014-08-01)

Comparison Of Bacillus anthracis Prepared Used Antigens As ‎Diagnostic kit Of Anthrax In Laboratoy Animals.‎
by: Al- Jebouri A.J. ‎, et al.
Published: (2007-06-01)

Analysis of the predictive value of the prostate-specific antigen-to-neutrophil ratio for the diagnosis of prostate cancer
by: Yuxuan Chen, et al.
Published: (2025-01-01)

Defining ‘Intention’ in intention-to-treat survival outcomes for chimeric antigen receptor T-cell therapy
by: Charles J. Milrod, et al.
Published: (2025-02-01)